Company intelligence / Profile preview

DKMS Stem Cell Bank

Dresden, Saxony, Germanyprofessional.dkms.org ↗

Ownership: Private
Development stage: Other

Overview

DKMS Stem Cell Bank is the first facility globally to make cryopreserved peripheral blood stem cells available for unrelated allogeneic transplantation. It also stores umbilical cord blood units. The bank supports rapid access to life-saving transplants, especially for patients with acute leukemia and other severe hematological diseases. It operates under GMP standards and NetCord–FACT accreditation, serving as a public resource for unrelated donor transplants.

Therapeutic areas: Hematology
Modalities: Stem cell therapyCell therapy
Industry: Academic Hospital/University/Research

Partnerships

Cooperation with University Hospital Carl Gustav Carus Dresden at founding; part of the broader DKMS network collaborating internationally.

Beyond the preview

Go deeper on DKMS Stem Cell Bank.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DKMS Stem Cell Bank.

Explore the full profile